Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis
- PMID: 8921985
- DOI: 10.1016/s0165-1110(96)90005-6
Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis
Abstract
Aflatoxin B1 (AFB1) is classified as a group I carcinogen in humans by IARC. However, the exact mechanisms of AFB1 hepatocarcinogenesis have not been fully elucidated. Recent studies have suggested that oncogenes are critical molecular targets for AFB1, and AFB1 causes characteristic genetic changes in the p53 tumor suppressor gene and ras protooncogenes. Up to date, more than 1500 human hepatocellular carcinoma (HCC) samples have been examined for p53 mutations with respect to different AFB1 exposure levels. The most significant finding is that more than 50% of HCC patients from high aflatoxin exposure areas such as southern Africa and Qidong, China harboured a codon 249 G to T transversion in the p53 tumor suppressor gene, which is found to be consistent with the mutagenic specificity of AFB1 observed in vitro. In contrast, this mutational pattern is not found in HCC samples from moderate or low aflatoxin exposure countries or regions. Therefore, this hot-spot mutation is believed to be a molecular fingerprint linking the initial event of AFB1-DNA adduct formation with the ultimate development and progress of human HCC. However, some important points still remain to be explicated. First, in many of these studies, the systematic evaluation of AFB1 exposure is rather limited and the classification of AFB1 exposure level is speculative and confusing, without the definite evidence for the actual aflatoxin exposure level. Second, the role of hepadnaviral infection has to be considered in the induction of this unique mutational spectrum. On the other hand, ras oncogene mutations are frequently found in AFB1-induced HCC samples in experimental animals, while the frequency of ras mutation in human HCC in contrast is much lower than that of p53. Recent studies have provided additional evidence that reactive oxygen species (ROS) and oxidative DNA damage may be involved in AFB1-induced p53 and ras mutations. In future, follow-up cohorts exposed to different levels of AFB1 combined with the determination of putative gene markers are much needed.
Similar articles
-
Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.Liver Int. 2011 Oct;31(9):1366-72. doi: 10.1111/j.1478-3231.2011.02572.x. Epub 2011 Jun 28. Liver Int. 2011. PMID: 21745313
-
p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.Cancer Res. 1997 Aug 15;57(16):3471-7. Cancer Res. 1997. PMID: 9270015
-
Geographic variation of p53 mutational profile in nonmalignant human liver.Science. 1994 May 27;264(5163):1317-9. doi: 10.1126/science.8191284. Science. 1994. PMID: 8191284
-
Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.Cancer Res. 1994 Apr 1;54(7 Suppl):1934s-1938s. Cancer Res. 1994. PMID: 7907948 Review.
-
DNA damage by mycotoxins.Mutat Res. 1999 Mar 8;424(1-2):167-81. doi: 10.1016/s0027-5107(99)00017-2. Mutat Res. 1999. PMID: 10064859 Review.
Cited by
-
Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes.Updates Surg. 2024 Jun;76(3):879-887. doi: 10.1007/s13304-024-01833-3. Epub 2024 Apr 7. Updates Surg. 2024. PMID: 38582796
-
Yeast polysaccharide mitigated oxidative injury in broilers induced by mixed mycotoxins via regulating intestinal mucosal oxidative stress and hepatic metabolic enzymes.Poult Sci. 2023 Sep;102(9):102862. doi: 10.1016/j.psj.2023.102862. Epub 2023 Jun 12. Poult Sci. 2023. PMID: 37419049 Free PMC article.
-
Role of p53 suppression in the pathogenesis of hepatocellular carcinoma.World J Gastrointest Pathophysiol. 2023 Jun 1;14(3):46-70. doi: 10.4291/wjgp.v14.i3.46. World J Gastrointest Pathophysiol. 2023. PMID: 37304923 Free PMC article. Review.
-
The Hydrophobic Extract of Sorghum bicolor (L. Moench) Enriched in Apigenin-Protected Rats against Aflatoxin B1-Associated Hepatorenal Derangement.Molecules. 2023 Mar 28;28(7):3013. doi: 10.3390/molecules28073013. Molecules. 2023. PMID: 37049776 Free PMC article.
-
Establishment of a prognostic model for predicting short-term disease-free survival in cases of hepatitis B-related hepatocellular carcinoma with the TP53 249Ser mutation in southern China.Transl Cancer Res. 2020 Aug;9(8):4517-4533. doi: 10.21037/tcr-19-2788. Transl Cancer Res. 2020. PMID: 35117817 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous